Table 5.
Contribution of individual nomogram risk factors on give risk of failure
| study | Stephenson119 | Kattan120 | Kattan 121 | Schroeck97 | Walz122 | |
| Other factors not shown below | Year of surgery | surgeon experience | Capsule invasion | Race, year of surgery, prostate weight | None | |
| Points for failure threshold | 172 Points for 10 yr failure >70% | 240 points for 10 yr failure >70% | 200 points for 7 year failure >60% | 150 points # for 5 yr failure >50% | 115 points for 2 yr failure >30% | |
| Risk factor points/% of points of failure threshold | ||||||
| LN+ | 11(6%) | 35 (15%) | 28 (14%) | ---- | 33(29%) | |
| ECE+ | 22(13%) | 35(15%) | 54(27%)* | 10 (7%) | 27(23%) | |
| SV+ | 23(13%) | 31(13%) | 26(13%) | 28(19%) | 49(43%) | |
| Mar + | 10(6%) | 35(15%) | 34(17%) | 35(23%) | 23(20%) | |
| Gl 4-6 | 0(0%) | 0(0%) | ≤ 6(<3%) | 0(0%) | 0(0%) | |
| Gl 7 | -- | 44(18%) | 30(15%) | -- | 54(47%) | |
| 3+4 | 14(8%) | -- | -- | 16(11%) | -- | |
| 4+3 | 33(19%) | -- | -- | 40(27%) | -- | |
| Gl 8-10 | 47(27%) | 88(37%) | -- | 49(33%) | 100(87%) | |
| -- | -- | 8 | 46(23%) | -- | -- | |
| -- | -- | 9 | 59(30%) | -- | -- | |
| -- | -- | 10 | 72(36%) | -- | -- | |
| PSA 2 | 72(42%) | 13(5%) | 65(33%) | 15(10%) | 2(2%) | |
| PSA 4 | 77(45%) | 28(12%) | 78(39%) | 30(20%) | 4(3%) | |
| PSA 5 | 80(47%) | 35(15%) | 82(41%) | 34(23%) | 5(4%) | |
| PSA 6 | 82(48%) | 42(18%) | 84(42%) | 37(25%) | 6(5%) | |
| PSA 8 | 83(48%) | 53(22%) | 88(44%) | 43(29%) | 9(8%) | |
| PSA 10 | 85(51%) | 60(25%) | 92(46%) | 50(33%) | 11(10%) | |
| 15 | 87(51%) | 71(30%) | 93(47%) | 58(39%) | 16(14%) | |
| 20 | 92(53%) | 73(30%) | 93(47%) | 65(43%) | 22(19%) | |
| 30 | 93(54%) | 77(32%) | 94(47%) | 73(49%) | 33(27%) | |
| 50 | 97(56%) | 83(35%) | 96(48%) | 85(57%) | 54(47%) | |
*average of focal (51 pts) and extensive EPE (57 pts)
#Used a 40 cc prostate which accounts for 35 points